All Infection Prevention & Control articles
-
NewsResearchers find increased bacteria infection in patients with chronic lung disease
A new study has found that people with bronchiectasis and chronic sinus disease were more likely to have mucus samples that tested positive for Pseudomonas aeruginosa. It suggests that doctors caring for patients with bronchiectasis may need to pay closer attention to sinus disease and bacterial testing.
-
NewsDiseases can spread between apartments via shared ventilation, study shows
Airborne diseases like measles, influenza and COVID-19 can easily spread between units in multi-family buildings via a type of bathroom ventilation system commonly used around the world, new research suggests.
-
NewsFriendly skin bacteria offer hope to beat eczema
Friendly skin bacteria could hold the key to stopping eczema in its tracks, according to researchers. A new study reveals harmless microbes living on our skin release powerful molecules that can shut down the inflammatory chaos triggered by Staphylococcus aureus, the bug long known to wreak havoc in eczema.
-
NewsExperts call on WHO to revisit its approach to airborne risk in light of hantavirus outbreak
In light of the hantavirus outbreak, public health experts have called on the World Health Organization (WHO) to shift its default response to emerging respiratory viruses. The starting point should not be to downplay the risk of airborne transmission until it is definitively proven, they warned.
-
NewsFlawed but correctable research hindered progress in infection-triggered chronic conditions
Researchers contend that studies of infection-associated chronic illnesses such as Lyme disease and COVID-19 suffer recurring problems such as the failure to prove participants have the relevant pathogen.
-
NewsThe liver’s immune cells might be the key to curing hepatitis B
Researchers investigated why some people with chronic hepatitis B infections went off their medications, only for the virus to start to come back — and then some of the patients were cured. It appears a certain type of T cell, some of which coordinate immune responses, spots the infection in the liver and mobilizes an attack.
-
NewsResearchers develop realistic ‘mock’ samples to speed cervical cancer test development
A team of bioengineers has developed a new way to create highly realistic “mock” patient samples that could help accelerate the development of faster, more accessible cervical cancer screening tests for low-resource settings.
-
NewsEurope advances genomic surveillance of CCRE with landmark multi-country study
New survey results provide the most comprehensive genomic picture to date of carbapenem- and/or colistin-resistant Enterobacterales (CCRE) across hospitals in Europe.
-
NewsBronchiectasis and NTM Care Center Network expands to 62 centers
The Bronchiectasis and NTM Association has accepted one new Care Center and three new Clinical Associate Center sites into the Bronchiectasis and NTM Care Center Network (CCN). The CCN includes 62 centers across the United States.
-
NewsFlu signals in wastewater offer an early warning for community outbreaks
A research team has demonstrated that measuring influenza viral RNA in wastewater can be used to estimate community influenza incidence. The approach may help identify outbreak trends about one week earlier than publicly available patient report data.
-
NewsNew health security operations center will monitor infectious disease risks during this summer’s World Cup gatherings
With millions of soccer fans set to descend on North America for the 2026 FIFA World Cup, experts from Georgetown University and MedStar Health have launched a pioneering Health Security Operations Center (HSOC) to monitor infectious disease transmission and mitigate global health risks.
-
NewsNo refrigeration needed for killer disease vaccine
Malaria kills more than half a million people every year, but a new vaccine is showing promise as it not only offers long-lasting strong protection but also inhibits transmission of malaria by mosquitos. The vaccine is predicted to be low cost and its cold-chain independence strongly enhances its deployability.
-
NewsResearchers develop promising drug candidate for control and elimination of malaria
Researchers have developed a novel chemical compound that shows promise for the treatment and prevention of malaria, one of the world’s deadliest diseases. T111 has the potential to become a single-encounter malaria drug that would simplify treatment and prevent relapses that drive ongoing transmission.
-
NewsAging immune systems show reduced ability to clear tuberculosis during treatment
Immunosenescence increases susceptibility to infectious diseases like tuberculosis (TB) in older adults and hinder effective containment of Mycobacterium tuberculosis during therapeutic intervention.
-
NewsCommentary: Dengue viral infection and associated liver disease
A new commentary highlights the time course of serological and liver enzyme elevations in mild versus severe dengue, emphasizes early recognition of progression to acute liver failure, and reviews current vaccination and prevention strategies.
-
NewsScientists discover ‘hidden switch’ in immune cells that helps the body kill deadly fungus
Scientists have discovered a “control switch” inside our immune cells that helps the body destroy dangerous fungal infections. A protein called RAB5c helps white blood cells kill Aspergillus fumigatus – an airborne fungus that can cause life‑threatening lung infections in people with weakened immune systems.
-
NewsWhat the Andes hantavirus outbreak reveals about pandemic risk
The outbreak of Andes hantavirus aboard the international MV Hondius cruise ship underscores how little scientists still know about the viruses circulating silently in wild rodent populations before they spill into humans.
-
NewsIntestinal stem cells can fight back against salmonella scientists discover
Researchers have shown that intestinal stem cells can directly sense intracellular Salmonella enterica bacteria and activate an inflammasome-dependent response. Following infection, the stem cells differentiate into antimicrobial Paneth cells, which secrete molecules that help limit bacterial persistence in the intestinal crypt.
-
NewsCRISPR system inhibits hepatitis E virus
Researchers have developed a novel antiviral concept - using the CRISPR/Cas13 system, they were able to specifically suppress the replication of the hepatitis E virus in human cells.
-
NewsAndes hantavirus outbreak: ECDC working on the frontline to support EU Member States
Genomic information also shows that the virus involved in the outbreak is similar to Andes viruses already known to circulate in South America, and is not a new variant. There is currently no evidence that this variant spreads more easily or causes more severe disease than other Andes viruses.